Skip to main content
Log in

Differential effects of amphetamine and neuroleptics on negative Vs. positive symptoms in schizophrenia

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Positive symptoms of schizophrenia were diminished by neuroleptics and increased by amphetamine and accounted for most of the change seen in the total Brief Psychiatric Rating Scale (BPRS). Negative symptoms in the same subjects were not affected by neuroleptics but increased after amphetamines to a degree that just attained statistical significance. This increase was due to one item (emotional withdrawal) of the negative symptom factor which responded to neuroleptics and amphetamines as did positive symptoms. These findings are discussed with respect to new ideas about the role of dopamine in schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Angrist B, Rotrosen J, Gershon S (1980) Response to apomorphine, amphetamine and neuroleptics in schizophrenic subjects. Psychopharmacology 67:31–38

    Google Scholar 

  • Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process? Brit Med J 280:66–68

    Google Scholar 

  • Guy W (1976) E.C.D.E.U. assessment manual for psychopathology. Washington D.C.: U.S. Department of Health, Education and Welfare, pp 160, 162, 167

    Google Scholar 

  • Itil TM, Marasa J, Saletu B, Davis S, Mucciardi AN (1975) Computerized EEG: predictor of outcome in schizophrenia. J Nerv Ment Dis 160:188–203

    Google Scholar 

  • Johnstone EC, Crow TJ, Frith CD, Carney MWP, Price JS (1978a) Mechanism of antipsychotic effect in the treatment of acute schizophrenia. Lancet 1:848–851

    Google Scholar 

  • Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L (1976) Cerebral ventricular size and cognitive impairment in schizophrenia. Lancet 2:924–926

    Google Scholar 

  • Johnstone EC, Crow TJ, Frith CD, Stevens M, Kreel L, Husband J (1978b) The dementia of dementia praecox. Acta Psychia Scand 57:304–324

    Google Scholar 

  • Melzer HY, Fang VS (1976) Serum prolactin levels in schizophrenia —effect of antipsychotic drugs: A preliminary report. In: Sachar EJ (ed) Hormones, behavior and psychopathology. Raven Press, New York, p 177

    Google Scholar 

  • Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2:19–76

    Google Scholar 

  • Spitzer RL, Endicot J, Robins E (1978) Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 35:733–782

    Google Scholar 

  • Weinberger DR, Bigelow LB, Kleinman JE, Klein ST, Rosenblatt JE, Wyatt RJ (1980) Cerebral ventricular enlargement in chronic schizophrenia: an association with poor response to treatment. Arch Gen Psychiat 37:11–13

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angrist, B., Rotrosen, J. & Gershon, S. Differential effects of amphetamine and neuroleptics on negative Vs. positive symptoms in schizophrenia. Psychopharmacology 72, 17–19 (1980). https://doi.org/10.1007/BF00433802

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00433802

Key words

Navigation